PFE : Analysis & Opinions

  • Showing 101-150 of 150 items
  • <<
  • 1
  • 2
  1. Pfizer's Ibrance Takes Another Giant Leap Forward (PFE)

    June 1, 2015
    Although its stock price may not reflect it, the past four-plus years have been perhaps the most challenging in Pfizer's ...
  2. Is Pfizer's Dividend Built to Last? (PFE)

    May 27, 2015
    Pfizer (NYSE: PFE) is the prototypical Big Pharma giant. Among megacap pharmaceutical names, Pfizer generates more revenue ...
  3. Would Pfizer Buying GlaxoSmithKline Make Sense? (GSK, PFE)

    May 22, 2015
    Over the past five years, Pfizer (NYSE: PFE) and its shareholders have witnessed its stock price ascend by approximately ...
  4. Who are Gilead Sciences' (GILD) main competitors?

    May 22, 2015
    Learn about the pharmaceutical company Gilead Sciences and its main competitors. Explore the company's role in creating HIV-preventing ...
  5. Who are Pfizer's (PFE) main competitors?

    May 20, 2015
    Learn about Pfizer's place in the pharmaceutical industry, and find out which major drug manufacturers are among its main ...
  6. 5 Things Pfizer's Management Wants You to Know (PFE)

    May 18, 2015
    It's been just shy of three weeks since pharmaceutical juggernaut Pfizer (NYSE: PFE) reported its first-quarter earnings ...
  7. Pfizer's 3 Most Important Numbers (PFE)

    May 8, 2015
    Pfizer (NYSE: PFE) is one of the largest and most profitable pharmaceutical companies in the world. Last year alone, it ...
  8. A Quick Guide To Healthcare ETFs

    May 8, 2015
    The healthcare industry offers a broad variety of sector ETFs but it’s difficult to avoid exposure to pharmaceuticals and ...
  9. How China Makes Money (PFE, GSK)

    April 28, 2015
    China has the first or second largest GDP in the world but is not nearly as developed as others in the top 10.
  10. How to Analyze Pharma Stock Fundamentals

    April 23, 2015
    What you need to know about analyzing the fundamentals of pharma stocks.
  11. Pfizer Earnings Preview: 5 Things You Need to Know (PFE, HSP)

    April 21, 2015
    Pfizer may not be the growth giant it was when it was riding cholesterol-fighting drug Lipitor's coattails to success, but ...
  12. Is This Pfizer's Next Mega-Blockbuster Drug? (PFE)

    April 16, 2015
    In February, the FDA delivered Pfizer (NYSE: PFE) some welcome news when it gave the company the go-ahead to begin marketing ...
  13. 3 Moves Pfizer Should Make for Its Shareholders (PFE, JAZZ)

    April 7, 2015
    PFE data by YCharts. Big pharmaceutical giant Pfizer (NYSE: PFE) isn't often thought of as a substantial growth driver of ...
  14. Is This Pfizer's Single Best Chance for Growth? (PFE)

    April 3, 2015
    Pfizer (NYSE: PFE) is a drug-developing Goliath, but it's struggled over the past few years to offset a drop-off in sales ...
  15. What are examples of major companies in the drugs sector?

    April 1, 2015
    Identify the major players in the drugs sector, which include many established pharmaceutical companies that have delved ...
  16. The Future of Big Pharma Stocks

    March 31, 2015
    A look at the future health of big pharma stocks.
  17. Four Key Pharmaceuticals ETFs To Consider

    March 25, 2015
    ETF funds are now very liquid investments and are suitable to investors who seek to match the price performance of the indexes ...
  18. Why These ETFs are the Best Way to Trade Pfizer

    March 17, 2015
    Looking to play Pfizer with diversification? Consider these ETFs.
  19. How A Strong Greenback Affects the Economy

    March 2, 2015
    The fact that the strong dollar has an effect on the US economy is indisputable, but is the overall impact positive or negative? ...
  20. Interested In Pharmaceutical Stocks? Try Novartis (ADR)

    February 26, 2015
    Novartis AG, is the world's leading pharmaceutical company by sales. Here is a closer look at Novartis, and how its financials ...
  21. How the S&P 500 and Russell 2000 Indexes Differ

    January 22, 2015
    The S&P 500 and Russell 2000 are used as benchmarks for broader segments of the U.S. stock market. Each index has its own ...
  22. The Best Way Into Big Pharma? See This ETF (IHE)

    November 21, 2014
    Pharma investing isn't for everyone, but sector-specific ETFs, such as the iShares Dow Jones U.S. Pharmaceuticals ETF (IHE), ...
  23. The Biggest Mergers & Acquisitions In The U.S.

    October 23, 2014
    M&A is a daily part of the American business world. They're based on the principle that "One plus one equals three," i.e. ...
  24. How Merck Found Its Way Into Millions Of Medicine Cabinets

    September 15, 2014
    With over $40 billion in revenue from pharmaceutical sales, there's a good chance that you'll be very grateful for one of ...
  25. Why There's Far More To Pfizer Than Viagra

    July 30, 2014
    Pfizer, Inc. is one of the world's largest and most profitable pharmaceutical companies, and not just because of that little ...
  26. Interested In Healthcare Stocks? Look At This ETF

    July 3, 2014
    Healthcare companies seem to be poised to make a move higher over the months ahead. Here's an ETF that should be helpful ...
  27. Invest In Share Buybacks With This ETF

    June 13, 2014
    In most cases, when a company buys its own shares on the open market it's a signal to investors that they're undervalued. ...
  28. #PreMarket Primer: Tuesday, May 27: Hope Rises In Ukraine Despite ...

    May 27, 2014
    Following the election of billionaire Petro Poroshenko as President of Ukraine, diplomatic tensions seemed to be easing ...
  29. What Are The Best Bets In Biotech?

    May 2, 2014
    The NASDAQ Biotechnology Index is off nearly 20% as its components busy themselves with hostile bids and frenzied buying ...
  30. How Johnson & Johnson Became A Household Name

    April 21, 2014
    New Brunswick, N.J.-based Johnson &amp; Johnson (NYSE:JNJ) is probably most famous as the parent company of multiple household ...
  31. It's No Accident That Drugs Are Expensive

    August 30, 2013
    Branded drugs are expensive in large part because it's expensive and risky to develop them
  32. 8 Stages Of New Drug Development

    July 29, 2013
    Understanding biotech data isn't easy. What is a clinical trial, what are the various phases, and why do the results of these ...
  33. Big Pharma Faces 'Pay For Delay' Lawsuits

    June 21, 2013
    Unless you follow the pharmaceutical and biotech sectors, it’s likely that you’ve never heard of pay to delay. Instead of ...
  34. The “Healthy” Play In Contract Research Organizations

    April 17, 2013
    The pharmaceutical industry is under pressure to do more with less. That means it will be farming out many of is mundane ...
  35. Bayer Buys Schiff Nutrition International: Winners All Around

    November 7, 2012
    Bayer announced November 2 that it's buying Schiff for $1.2 billion to bulk up its consumer business.
  36. Pfizer's Third Quarter Earnings Report

    November 1, 2012
    Pfizer (NYSE:PFE) announced its results for the most recent quarter on November 1, 2012. Pfizer is a global pharmaceutical ...
  37. Pfizer Is Near a Key Resistance Area

    September 27, 2012
    New York, September 27th (TradersHuddle.com) - Shares of Pfizer, Inc. (NYSE:PFE) are trading very close to calculated resistance ...
  38. 5 Easy Ways to Cash In on US Dividends

    April 26, 2012
    If you’re outside the US looking in, there are important pros and cons to adding exchange traded funds from America to your ...
  39. Nestle Almost Never On Sale

    April 24, 2012
    Nestle has a well-earned reputation for excellence and the Street has long been happy to pay a premium for that performance. ...
  40. Birth Control Subsidies Slashed: Will Big Pharma Take A Hit?

    March 6, 2012
    Several states have already slashed birth control subsidies. Learn how this will affect pharmaceutical stocks.
  41. Slow And Steady ETFs Outperforming

    January 3, 2012
    Low volatility ETFs lead the way in 2011.
  42. PPD Goes Private

    October 6, 2011
    PPD's acceptance of a low buyout bid raises questions about the CRO industry.
  43. 10 Drug Stocks for Safety and Yields

    June 26, 2011
    Big pharma is an attractive destination for traders and investors looking for safety, yields, and solid value in the current ...
  44. 5 Low-Beta DJIA Stocks To Know

    December 14, 2010
    Check out five low-beta stocks that can help you to diversify your portfolio.
  45. 7 Reasons To Pick ETFs Over Stocks

    November 1, 2010
    As a cost-effective way to achieve a broadly diversified portfolio, including hard-to-own (but worthwhile) assets, ETFs are ...
  46. Invest In The Lip Balm Portfolio

    October 5, 2010
    Themed portfolios can often exceed established ones in performance - and the lip balm portfolio is just one example.
  47. Biotech Stocks Ready Ready To Break Out

    September 7, 2010
    Biotech Stocks Ready Ready To Break Out
  48. 4 U.S. Companies With High Currency Exposure

    February 24, 2010
    The U.S. dollar has been strengthening against the euro which is a bad sign for the U.S. exporters as the goods become more ...
  49. The 5 Most Important Drugs In America

    July 28, 2009
    A look at the top-selling drugs finds that a few that make more of a difference to the company's bottom line than others.
  50. Is Pfizer What The Doctor Ordered Or Bad Medicine?

    April 30, 2009
    Explore Pfizer, its earnings and its recent acquisition deal.
  • Showing 101-150 of 150 items
  • <<
  • 1
  • 2
Trading Center